The first patients are now being treated as part of a first-in-human trial of a vaccine, administered as a nasal spray, that aims to slow down the progression of Alzheimer's disease (AD).
Johnson & Johnson's SGLT2 inhibitor Invokana has been shown to have a significant effect on heart failure symptoms in a clinical trial that relied entirely on remote monitoring of sympt
After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operation
Johnson & Johnson has reached an agreement to make its one-dose COVID-19 vaccine available to an arm of the COVAX facility that is focusing on providing shots to around 167 million disp
Tech giant Apple has appointed Johnson & Johnson's chief executive Alex Gorsky to its board, revealing once again its ambitions in the healthcare arena.
The US looks set to see a big expansion of the country's COVID-19 vaccination drive, with shots looking likely for children aged five to 11 as well as a fourth dose for adults who are immun